Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD (Q37791005)

23 August 2017

title

Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD (English)

1 reference

https://api.crossref.org/works/10.1007/S00784-010-0450-6

17 July 2024

Hildegard Greinix

1 reference

23 August 2017

Johannes K-H Meier

1 reference

23 August 2017

Daniel Wolff

1 reference

23 August 2017

Steve Pavletic

1 reference

23 August 2017

Martin Gosau

1 reference

23 August 2017

Hartmut Bertz

1 reference

23 August 2017

Anita Lawitschka

1 reference

23 August 2017

Sharon Elad

1 reference

23 August 2017

International Consensus Conference on Clinical Practice in cGVHD

1 reference

23 August 2017

Stefanie J. Lee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20859645

17 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20859645

17 July 2024

publication date

22 September 2010

1 reference

full work available at URL

23 August 2017

http://link.springer.com/content/pdf/10.1007/s00784-010-0450-6.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S00784-010-0450-6

http://link.springer.com/article/10.1007/s00784-010-0450-6/fulltext.html

17 July 2024

1 reference

https://api.crossref.org/works/10.1007/S00784-010-0450-6

http://link.springer.com/content/pdf/10.1007/s00784-010-0450-6

17 July 2024

1 reference

https://api.crossref.org/works/10.1007/S00784-010-0450-6

Clinical Oral Investigations

17 July 2024

published in

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

127-139

1 reference

Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Wo

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Pathophysiology of graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

21 January 2018

Graft-vs.-host disease

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Xerostomia: evaluation of a symptom with increasing significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

An update of the etiology and management of xerostomia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Scleroderma, Sjögren-like Syndrome, and Chronic Graft-Versus-Host Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Solid cancers after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Oral malignancies following HSCT: graft versus host disease and other risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Oral chronic graft-versus-host disease scoring using the NIH consensus criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Chronic graft versus host disease of oral mucosa: review of available therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Budesonide: a novel treatment for oral chronic graft versus host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Pharmacokinetics and pharmacodynamic action of budesonide after buccal administration in healthy subjects and patients with oral chronic graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Severe oral manifestations of chronic graft-vs.-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions: an open label clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Intraoral psoralen ultraviolet A irradiation (PUVA) treatment of refractory oral chronic graft-versus-host disease following allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Ultraviolet B irradiation: a new therapeutic concept for the management of oral manifestations of graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Successful treatment of oral lesions of chronic lichenoid graft-vs.-host disease by the addition of low-level laser therapy to systemic immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Lidocaine toxicity during frequent viscous lidocaine use for painful tongue ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Systemic absorption of lidocaine after topical application for the treatment of oral mucositis in bone marrow transplantation patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Potential utility of peripherally applied loperamide in oral chronic graft-versus-host disease related pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

CO2 laser in oral graft-versus-host disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Pilocarpine hydrochloride for symptomatic relief of xerostomia due to chronic graft-versus-host disease or total-body irradiation after bone-marrow transplantation for hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

The effect of pilocarpine on salivary constituents in patients with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Salivary gland dysfunction: a review of systemic therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Review of the Pharmacological Properties and Clinical Usefulness of Muscarinic Agonists for Xerostomia in Patients with Sjögren's Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Saliva substitutes for the treatment of radiation-induced xerostomia--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Oral complications of pediatric hematopoietic cell transplantation: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Electrostimulating device in the management of xerostomia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Orthodontic treatment in long-term survivors after pediatric bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Long-term adverse effects of hematopoietic stem cell transplantation on dental development in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Dental treatment planning and management in the patient who has cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and t

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Osteonecrosis of the jaws and bisphosphonate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Osteonecrosis of the jaw and bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

21 January 2018

Oral cytology revisited

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00784-010-0450-6

Analysis of new diagnostic methods in suspicious lesions of the oral mucosa.

21 January 2018

1 reference

12 December 2020

Cevimeline reduced mouth dryness and increased salivary flow in patients with xerostomia complicating chronic graft-versus-host disease

1 reference

12 December 2020

American Association of Oral and Maxillofacial Surgeons position paper: Bisphosphonate-Related Osteonecrosis of the Jaws-2009 update: the need to refine the BRONJ definition

1 reference

12 December 2020

Oral manifestations of chronic graft-v-host disease

1 reference

12 December 2020

Lichenoid graft-vs-host disease in an autologous bone marrow transplant recipient

1 reference

12 December 2020

PUVA therapy for drug-resistant graft-versus-host disease

1 reference

12 December 2020

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update

1 reference

12 December 2020

Effect of pilocarpine hydrochloride on unstimulated whole saliva flow rate and composition in patients with chronic graft-versus-host disease (cGVHD)

1 reference

12 December 2020

Treatment of oral chronic graft-versus-host disease with PUVA therapy: case report and literature review

1 reference

12 December 2020

Dental endosseous implants in patients on bisphosphonate therapy

1 reference

12 December 2020

Oral graft-versus-host disease

1 reference

12 December 2020

Topical cyclosporin A for treatment of oral chronic graft-versus-host disease

1 reference

12 December 2020

Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease

1 reference

12 December 2020

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial

1 reference

12 December 2020

Chronic graft versus host disease

1 reference

12 December 2020

Severe gingival recession and early loss of teeth in a child with chronic graft versus host disease: a case report

1 reference

12 December 2020

Recognition, incidence, and management of oral graft-versus-host disease

1 reference

12 December 2020

Guideline on dental management of pediatric patients receving chemotherapy, hematopoietic cell transplantation, and/or radiation

1 reference

12 December 2020

Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases

1 reference

12 December 2020

Graft-versus-host disease

1 reference

12 December 2020

Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.

1 reference

12 December 2020

Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.

1 reference

12 December 2020

The effect of budesonide mouthwash on oral chronic graft versus host disease

1 reference

12 December 2020

Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients

1 reference

12 December 2020

Oral graft vs. host disease in children--treatment with topical tacrolimus ointment

1 reference

12 December 2020

Oral graft-versus-host disease: successful therapy with extracorporeal photopheresis and topical tacrolimus.

1 reference

12 December 2020

Dramatic increase of tacrolimus plasma concentration during topical treatment for oral graft-versus-host disease

1 reference

12 December 2020

Gingival squamous cell carcinoma in a patient with chronic graft-versus-host disease

1 reference

12 December 2020

Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease

1 reference

12 December 2020

Systemic absorption of lidocaine after topical application for the treatment of oral mucositis in bone marrow transplantation patients

1 reference

12 December 2020

Deutsche zahnarztliche Zeitschrift

510

Groetz

2006

1 reference

https://api.crossref.org/works/10.1007/S00784-010-0450-6

17 July 2024

Identifiers

1 reference

release_b5fvxcz5kfeedckpnzv4ndgnwi

23 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/b5fvxcz5kfeedckpnzv4ndgnwi

24 November 2022

mapped directly with Wikidata item

1 reference